Lack of evidence for isozymic shifts of adenylate deaminase during hepatocarcinogenesis.
D015073:2-Acetylaminofluorene / Q000494:pharmacology; D000659:AMP Deaminase / Q000302:isolation & purification / Q000378:metabolism*; D000818:Animals; D002852:Chromatography, Ion Exchange; D005001:Ethionine / Q000494:pharmacology; D005260:Female; D007527:Isoenzymes / Q000378:metabolism*; D008099:Liver / Q000187:drug effects; D008113:Liver Neoplasms / Q000032:analysis / Q000139:chemically induced / Q000201:enzymology*; D008749:Methyldimethylaminoazobenzene / Q000494:pharmacology; D009709:Nucleotide Deaminases / Q000378:metabolism*; D051381:Rats; D013853:Thioacetamide / Q000494:pharmacology
D007527:Isoenzymes; D013853:Thioacetamide; D008749:Methyldimethylaminoazobenzene; D015073:2-Acetylaminofluorene; D009709:Nucleotide Deaminases; D000659:AMP Deaminase; D005001:Ethionine